Pituitary-thyroid hormone interactions in states of hyper- and hypothyroidism: Clinical implications in 2000

Endocrinologist

Volumn 10, Issue 2, 2000, Pages 118-123

  Shetty, Archana ^a   Wilber, John F ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; GONADOTROPIN; GROWTH HORMONE; HYDROCORTISONE; PROLACTIN; PROTIRELIN; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; THYROID HORMONE; THYRONINE; THYROTROPIN; THYROXINE;

ADRENAL INSUFFICIENCY; ELECTROLYTE BALANCE; FLUID BALANCE; GALACTORRHEA; GROWTH DISORDER; HUMAN; HYPERPLASIA; HYPERPROLACTINEMIA; HYPERTHYROIDISM; HYPOPHYSIS; HYPOPHYSIS ADENOMA; HYPOPHYSIS DISEASE; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; HYPOTHYROIDISM; MALE SEXUAL DYSFUNCTION; MENSTRUATION DISORDER; PRECOCIOUS PUBERTY; REVIEW; SUBFERTILITY;

EID: 0034087412     PISSN: 10512144     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019616-200010020-00007     Document Type: Review

References (24)

1. Silva JE: Pituitary-thyroid relationships in hypothyroidism. Bailliere's Clin Endocrinol Metab 1988; 2: 541-65.
2. Iranmanesh A, Lizarralde G, Johnson ML, Veldhuis JD: Nature of altered growth hormone secretion in hyperthyroidism. J Clin Endocrinol Metab 1991; 72: 108-15.
3. Braverman LE, Utiger RD: Warner and Ingbar's The Thyroid, Seventh Edition. Philadelphia, Lippincott-Raven Publishers 1996.
4. Williams T, Maxon H, Thomer MO, Frohman LA: Blunted growth hormone (GH) response to GH-releasing hormone in hypothyroidism resolves in the euthyroid state. J Clin Endocrinol Metab 1985:61:454-6.
5. Valcavi R, Valente F, Dieguez C, et al.: Evidence against depletion of the growth hormone (GH)-releasable pool in human primary hypothyroidism: studies with GH-releasing hormone, pyridostigmine, and arginine. J Clin Endocrinol Metab 1993; 77: 616-20.
6. Miell JP, Taylor AM, Zini M, Maheshwari HG, Ross RJM, Valcavi R: Effects of hypothyroidism and hyperthyroidism on insulin-like growth factors (IGFs) and growth hormone- and IGF-binding proteins. J Clin Endocrinol Metab 1993; 76: 950-5.
7. Ramos-Dias JC, Pimentel-Filho F, Reis AF, Lengyel AJ: Different growth hormone (GH) response to GH-releasing peptide and GHreleasing hormone in hyperthyroidism. J Clin Endocrinol Metab 1996:81:1343-6.
8. Ramos-Dias JC, Yateman M, Camacho-Hubner C, Grossman A, Lengyel AJ: Low circulating IGF-1 levels in hyperthyroidism are associated with decreased GH response to GH-releasing hormone. Clin Endocrinol (Oxf) 1995; 43: 583-9.
9. Anasti JN, Flack MR, Froehlich J, Nelson LM, Nisula BC: A potential novel mechanism for precocious puberty in juvenile hypothyroidism. J Clin Endocrinol Metab 1995; 80: 276-9.
10. Buchanan CR, Stanhope R, Adlard P, Jones J, Grant DB, Preece MA: Gonadotrophin, growth hormone and prolactin secretion in children with primary hypothyroidism. Clin Endocrinol (Oxf) 1988; 29:427-36.
11. Pringle PJ, Stanhope R, Hindmarsh P, Brook CGD: Abnormal pubertal development in primary hypothyroidism. Clin Endocrinol (Oxf) 1988; 28: 479-86.
12. DeGroot LJ, Larsen PR, Hennemann G: The thyroid and its diseases, Sixth Edition. New York, Churchhill-Livingstone 1996.
13. Akande EO, Hockaday TDR: Plasma concentration of gonadotrophins, oestrogens and progesterone in thyrotoxic women. Br J Obstet Gynaecol 1975; 82: 541-51.
14. Kidd GS, Glass AR, Vigersky RA: The hypothalamic-pituitarytesticular axis in thyrotoxicosis. J Clin Endocrinol Metab 1979; 48: 798-802.
15. Smith CR, Butler J, Norman MR: Biological activity of serum prolactin in patients with primary hypothyroidism. Ann Clin Biochem 1988; 25 (Pt 5): 540-5.
16. Bigos SR, Ridgeway EC, Kourides IA, Maloof F: Spectrum of pituitary alterations with mild and severe thyroid impairment. J Clin Endocrinol Metab 1978; 46: 317-25.
17. Erfurth EM, Hedner P: Suppressed plasma prolactin response to thyrotropin-releasing hormone in hyperthyroidism reproduced by thyroxine but not by triiodothyronine administration to normal subjects. Acta Endocrinol (Copenh) 1988; 117: 241-8.
18. Kamilaris TC, DeBold CR, Pavlou SN, Island DP, Hoursanidis A, Orth DN: Effect of altered thyroid hormone levels on hypothalamicpituitary-adrenal function. J Clin Endocrinol Metab 1987; 65:994-9.
19. Iranmanesh A, Lizarralde G, Johnson LJ, Veldhuis JD: Dynamics of 24-hour endogenous Cortisol secretion and clearance in primary hypothyroidism assessed before and after partial thyroid hormone replacement. J Clin Endocrinol Metab 1990; 70: 155-61.
20. Hanna FW, Scanlon MF: Hyponatremia, hypothyroidism, and role of arginine-vasopressin. Lancet 1997; 350: 755-6.
21. Beck-Peccoz P, Persani L, Asteria C, et al.: Thyrotropin-secreting pituitary tumors in hyper- and hypothyroidism. Acta Med Austriaca 1997; 23 (1-2): 41-6.
22. Beck-Peccoz P, Amr S, Menezes-Ferreira MM, Faglia G, Weintraub BD: Decreased receptor binding of biologically inactive thyrotropin in central hypothyroidism. Effect of treatment with thyrotropinreleasing hormone. N Engl J Med 1985; 312: 1085-90.
23. Samuels MH: Thyrotropin-secreting pituitary tumors. In Contemporary Endocrinology, Volume 3: Diseases of the Pituitary: Diagnosis and Treatment, edited by Wierman ME, pp. 295-303, Totowa, NJ, Humana Press 1997.
24. Tagami T, Gu W-X, Peairs FT, West BL, Jameson JL: A novel natural mutation in the thyroid hormone receptor defines a dual functional domain that exchanges nuclear receptor compressors and coactivators. Mol Endocrinol 1998; 12: 1888-902.